• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经正中枕下锁孔经天幕入路显微外科治疗第四脑室病变。

Microsurgical Management of Fourth Ventricle Lesions Via the Median Suboccipital Keyhole Telovelar Approach.

机构信息

Department of Neurosurgery, the Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, China.

出版信息

J Craniofac Surg. 2023;34(2):607-610. doi: 10.1097/SCS.0000000000008883. Epub 2022 Aug 15.

DOI:10.1097/SCS.0000000000008883
PMID:35968951
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9944752/
Abstract

In this 2-year retrospective analysis, 13 patients with fourth ventricle lesions who underwent microsurgical resection via the midline suboccipital keyhole telovelar approach were analyzed. This is the first study to investigate the surgical outcome and complications of using this approach to resect various types of lesions in the fourth ventricle. We aimed to clarify whether this approach has met its promise of lesion dissection. Three patients (23.1%) had intraoperative extraventricular drains. There were no immediate postoperative deaths. Gross total resection was achieved in 84.6% of the cases. The Fisher exact test showed there was no statistically significant correlation between lesion location, lesion size, brainstem invasion, and extent of resection. About two third (69.2%) of the cases were free of complications. New or worsening gait/focal motor disturbance (15.4%) was the most common neurological deficit in the immediate postoperative period. One patient (7.7%) had worse gait disturbance/motor deficit following surgical intervention. Two patients (15.4%) developed meningitis. Two patients (15.4%) required postoperative cerebrospinal fluid diversion after tumor resection, of these 2 patients, 1 (7.7%) eventually needed a permanent shunt. There were no cases of cerebellar mutism and bulbar paralysis. The median suboccipital keyhole telovelar approach provides relative wide access to resect most fourth ventricle tumors completely and with satisfactory results. In contrast, this requires the appropriate patient selection and skilled surgeons.

摘要

在这项为期 2 年的回顾性分析中,分析了 13 例经中线枕下小骨窗经穹窿间入路行显微切除术的第四脑室病变患者。这是首次研究使用该入路切除第四脑室各种类型病变的手术结果和并发症的研究。我们旨在阐明该入路是否符合其病变解剖的承诺。3 例(23.1%)患者在术中行额外脑室引流。无术后即刻死亡。84.6%的病例达到大体全切除。Fisher 确切检验显示,病变部位、病变大小、脑干侵犯和切除范围之间无统计学显著相关性。约三分之二(69.2%)的病例无并发症。新出现或恶化的步态/局灶性运动障碍(15.4%)是术后即刻最常见的神经功能缺损。1 例(7.7%)患者在手术干预后出现步态障碍/运动功能减退。2 例(15.4%)发生脑膜炎。2 例(15.4%)患者在肿瘤切除后需要术后脑脊液引流,其中 1 例(7.7%)最终需要永久性分流。无小脑缄默症和延髓性瘫痪病例。中位枕下小骨窗经穹窿间入路可提供相对广泛的入路,以完全切除大多数第四脑室肿瘤,并取得满意的结果。相比之下,这需要适当的患者选择和熟练的外科医生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e060/9944752/4566aede562c/scs-34-0607-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e060/9944752/a33e4abd0df5/scs-34-0607-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e060/9944752/4566aede562c/scs-34-0607-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e060/9944752/a33e4abd0df5/scs-34-0607-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e060/9944752/4566aede562c/scs-34-0607-g003.jpg

相似文献

1
Microsurgical Management of Fourth Ventricle Lesions Via the Median Suboccipital Keyhole Telovelar Approach.经正中枕下锁孔经天幕入路显微外科治疗第四脑室病变。
J Craniofac Surg. 2023;34(2):607-610. doi: 10.1097/SCS.0000000000008883. Epub 2022 Aug 15.
2
Telovelar vs. Transvermian approach for the fourth ventricle tumors: A systematic review and meta-analysis.穹窿间入路与经天幕入路切除第四脑室肿瘤:系统评价和荟萃分析。
Clin Neurol Neurosurg. 2024 May;240:108259. doi: 10.1016/j.clineuro.2024.108259. Epub 2024 Mar 26.
3
The surgical treatment of tumors of the fourth ventricle: a single-institution experience.第四脑室肿瘤的外科治疗:单中心经验。
J Neurosurg. 2018 Feb;128(2):339-351. doi: 10.3171/2016.11.JNS161167. Epub 2017 Apr 14.
4
The surgical management of third ventricle region tumors.第三脑室区域肿瘤的手术治疗。
Clin Neurol Neurosurg. 2024 Nov;246:108564. doi: 10.1016/j.clineuro.2024.108564. Epub 2024 Sep 21.
5
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
6
What Are the Recurrence Rates, Complications, and Functional Outcomes After Multiportal Arthroscopic Synovectomy for Patients With Knee Diffuse-type Tenosynovial Giant-cell Tumors?膝关节弥漫型腱鞘巨细胞瘤患者行多入路关节镜下滑膜切除术的复发率、并发症及功能结局如何?
Clin Orthop Relat Res. 2024 Jul 1;482(7):1218-1229. doi: 10.1097/CORR.0000000000002934. Epub 2023 Dec 28.
7
Composite Reconstruction With Irradiated Autograft Plus Total Hip Replacement After Type II Pelvic Resections for Tumors Is Feasible but Fraught With Complications.肿瘤Ⅱ型骨盆切除术后采用同种异体骨移植加全髋关节置换术进行复合重建是可行的,但并发症多。
Clin Orthop Relat Res. 2024 Oct 1;482(10):1825-1835. doi: 10.1097/CORR.0000000000003097. Epub 2024 Apr 26.
8
Surgical management of the fourth ventricular tumors using telovelar approach and the role of neuroendoscopy: Post-operative outcome and long-term results in a series of 52 cases.经穹窿入路切除第四脑室肿瘤的手术治疗及神经内镜的作用:52 例患者的术后结果和长期疗效。
Clin Neurol Neurosurg. 2021 Feb;201:106419. doi: 10.1016/j.clineuro.2020.106419. Epub 2020 Dec 8.
9
Infradentate Approach to the Fourth Ventricle with Tubular Retraction System for Medulloblastoma: Feasibility of a Minimally Invasive Technique to Avoid Anatomical Complications in a Pediatric Patient.使用管状牵开系统经齿状突下入路治疗髓母细胞瘤第四脑室:一种避免小儿患者解剖学并发症的微创技术的可行性
Pediatr Neurosurg. 2025;60(1-2):45-50. doi: 10.1159/000545010. Epub 2025 Mar 3.
10
Endoscopic third ventriculostomy (ETV) for idiopathic normal pressure hydrocephalus (iNPH).内镜下第三脑室造瘘术(ETV)治疗特发性正常压力脑积水(iNPH)。
Cochrane Database Syst Rev. 2015 Jul 29;2015(7):CD010033. doi: 10.1002/14651858.CD010033.pub2.